I. General Principles 1.The Epigenetic Machinery in the Life Cycle 2. Pharmacoepigenetics: Basic Principles for Personalized Medicine 3. Pharmacoepigenetic Processors 4. Epigenetic regulation of genes involved in drug metabolism 5. MicroRNA-Dependent Gene Regulation of the Human Cytochromes P450 6. Epigenetic regulation of transporter genes 7.
Pathoepigenetics: The Role of Epigenetic Biomarkers in Disease Pathogenesis II. Drug Development and Drug-related events 8. Epigenetic Drugs 9. Pharmacoepigenetics of Novel Nucleoside DNA Methyltransferase Inhibitors 10. Pharmacoepigenetics: Novel Mechanistic Insights in Drug Discovery and Development Targeting Chromatin-Modifying Enzymes 11. Pharmacoepigenetics of EZH2 Inhibitors 12. Regulators of Histone Acetylation: Bromodomain Inhibitors 13. Bromodomain Inhibition and Its Application to Human Disease 14.
Pharmacoepigenetics of Brassica-Derived Compounds 15. Pharmacological Nicotinamide: Mechanisms Centered Around SIRT1 Activity 16. Epigenetic-related Drug Resistance 17. Toxicoepigenetics III. Pharmacoepigenetics of Cancer 18. Epigenetics of Aging and Cancer: A Comprehensive Look 19. Epigenetic Drug Discovery for Cancer 20. Pharmacoepigenetics of Histone Deacetylase Inhibitors in Cancer 21.
Pharmacoepigenetics of LSD1 Inhibitors in Cancer 22. Epigenetic effects of AntiGan in Cancer 23. Pharmacoepigenetic Considerations for the Treatment of Breast Cancer 24. Pharmacoepigenetics of Acute Myeloid Leukemia 25. Therapeutic Potential of Pharmacoepigenetics in Cholangiocarcinoma 26. Pharmacoepigenetics of Gastrointestinal disorders and Cancer 27. Pharmacoepigenetics of Chinese Herbal Components in Cancer IV. Pharmacoepigenetics of Cardiovascular disease and Related disorders 28.
Epigenetics and Pharmacoepigenetics of myocardial infarction 29. Epigenetics and Pharmacoepigenetics of Arteriosclerosis 30. Epigenetics and Pharmacoepigenetics of Hypertension 31. Pharmacoepigenetics of Ancoagulants 32. Epigenetics in Doxorubicin Cardiotoxicity 33. Epigenetic effects of CardioSar in cardiovascular disorders V. Pharmacoepigenetics of Central Nervous System disorders 34. Epigenetics and Pharmacoepigenetics of Neurodevelopmental and Neuropsychiatric Disorders 35.
Pharmacoepigenetics and Toxicoepigenetics in Neurodevelopmental Disorders 36. Pharmacoepigenetics of Autism Spectrum Disorder 37. Pharmacoepigenetics of Antipsychotic Drugs 38. Pharmacoepigenetics of Bipolar Disorder 39. Pharmacoepigenetics of Major Depression 40. Epigenetics and Pharmacoepigenetics of Vestibulocochlear disorders 41. Epigenetics and Pharmacoepigenetics of Visual disorders 42. Epigenetics and Pharmacoepigenetics of Age-Related Neurodegenerative Disorders 43.
Epigenetic effects of Nosustrophine in Alzheimer''s disease 44. Epigenetic effects of Atremorine in Parkinson''s disease 45. Pharmacoepigenetics and Pharmacoepigenomics of Valproate in Neurodegenerative Disease 46. Pharmacoepigenetics of Memantine in Dementia VI. Pharmacoepigenetics of Metabolic and Endocrine disorders 47. Pharmacoepigenetics in Type 2 Diabetes Mellitus 48. Epigenetics and Pharmacoepigenetics of hypercholesterolemia and lipid metabolism disorders 49. Pharmacoepigenetics of Statins 50.
Epigenetics and Pharmacoepigenetics of Thyroid disorders VII. Pharmacoepigenetics of Immunological and Inflammatory disorders 51. Pharmacoepigenetics of Immunological Disorders 52. Pharmacoepigenetics of Rheumatic Disorders 53. Epigenetics and Pharmacoepigenetics of Skin disorders 54. Pharmacoepigenetics of Systemic Lupus Erythematosus V III. Nutritional Epigenetics 55. Nutriepigenetics 56.
Epinutraceuticals: Novel biomolecules with epigenetic effects IX. Epigenetics and Pharmacoepigenetics of infectious disorders 57. Pharmacoepigenetic of bacterial infections 58. Pharmacoepigenetics of viral infections 59. Pharmacoepigenetics of COVID-19 X. Mendelian epigenetic disorders 60. Pharmacoepigenetics of Mendelian disorders associated with the epigenetic machinery.